Reduced expression of CDH1 and KRT18 was significantly associated with high-grade tumors and non-endometrioid tumor histology, while increased expression CTSB, CDH2 and ZEB1 could be observed in serous tumors (Fig. 5E, F). The gene discussed is KRT18; the disease is endometrioid tumor.